Stockscreener 앱 받기
73.09
0.66%
0.48
전일 마감가:
$72.61
열려 있는:
$71.93
하루 거래량:
4.07M
Relative Volume:
3.26
시가총액:
$12.65B
수익:
$8.31B
순이익/손실:
$379.00M
주가수익비율:
33.84
EPS:
2.16
순현금흐름:
$385.00M
1주 성능:
+3.22%
1개월 성능:
+10.32%
6개월 성능:
+2.21%
1년 성능:
+25.26%
1일 변동 폭
$71.34
$73.51
1주일 범위
$71.21
$73.51
52주 변동 폭
$47.16
$85.92
Solventum Corp Stock (SOLV) Company Profile
명칭
Solventum Corp
전화
651-733-1110
주소
C/O 3M COMPANY, ST. PAUL
SOLV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
73.09 | 12.25B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
552.34 | 193.38B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
172.59 | 49.12B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.94 | 42.79B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
244.79 | 35.61B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
30.50 | 15.46B | 11.89B | -560.00M | 191.00M | -1.10 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-19 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-10-08 | 개시 | Stifel | Buy |
| 2024-10-07 | 개시 | Piper Sandler | Neutral |
| 2024-09-26 | 개시 | Wolfe Research | Peer Perform |
| 2024-09-05 | 개시 | BTIG Research | Neutral |
| 2024-06-24 | 개시 | Argus | Hold |
| 2024-05-30 | 개시 | Goldman | Sell |
| 2024-05-10 | 개시 | BofA Securities | Neutral |
| 2024-04-10 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-04-08 | 개시 | Wells Fargo | Equal Weight |
| 2024-04-02 | 개시 | Edward Jones | Hold |
모두보기
Solventum Corp 주식(SOLV)의 최신 뉴스
Solventum Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Ameriprise Financial Inc. Boosts Stake in Solventum Co. (NYSE:SOLV) - Defense World
Ensemble and Solventum to launch autonomous coding solution for hospitals - Yahoo Finance
Piper Sandler Upgrades Solventum (BIT:1SOLV) - Nasdaq
Piper Sandler Upgrades Solventum (LSE:0AD1) - Nasdaq
Ensemble and Solventum Partner to Advance Autonomous Inpatient Coding with AI - The Manila Times
Piper Sandler Upgrades Solventum (BMV:SOLV) - Nasdaq
Piper Sandler Upgrades Solventum (SOLV) - Nasdaq
Assessing Solventum: Insights From 9 Financial Analysts - Benzinga
Piper Sandler raises Solventum stock to Overweight, target to $87 By Investing.com - Investing.com Nigeria
Piper Sandler raises Solventum stock to Overweight, target to $87 - Investing.com
Piper Sandler Upgrades Solventum to Overweight From Neutral, Adjusts Price Target to $87 From $78 - marketscreener.com
Solventum upgraded to Overweight from Neutral at Piper Sandler - TipRanks
Promising Growth and Strategic Flexibility: A Buy Recommendation for Solventum Corporation - TipRanks
After spinoff, 3M is no longer one of Minnesota’s five largest public companies - MSN
Solventum's (NYSE:SOLV) Shareholders Have More To Worry About Than Only Soft Earnings - simplywall.st
Solventum's (NYSE:SOLV) Problems Go Beyond Weak Profit - Yahoo Finance
Solventum Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Solventum Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
People moves: Linda Pazin joins Solventum and Mitch Haws moves to Semtech - IR Impact
Solventum To Present At BofA Securities Health Care Conference; Webcast At 5:20 PM ET - Nasdaq
Solventum sells purification business for $4.1B to pay down debt - MSN
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - MSN
Solventum’s projected $100M tariff hit prevents earnings increase - MedTech Dive
Solventum (SOLV) Just Overtook the 200-Day Moving Average - Nasdaq
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline - MSN
Solventum, facing tariffs of up to $100 million, raises sales guidance - MSN
Solventum Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st
Decoding Solventum Corp (SOLV): A Strategic SWOT Insight - GuruFocus
Solventum beats first-quarter profit estimates on strong surgical product sales - MSN
Solventum (SOLV) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN
Solventum beats The Street in Q1 and ups revenue guidance - MassDevice
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
Solventum Corporation: Cheap, With Caveats (NYSE:SOLV) - Seeking Alpha
Health care manufacturer Solventum faces $100 million tariff hit despite strong Q1 - The Business Journals
Solventum price target lowered to $78 from $80 at Piper Sandler - TipRanks
Solventum Q1 FY25 presentation: raises organic sales outlook despite tariff headwinds - Investing.com
Solventum: Q1 Earnings Snapshot - New Haven Register
Solventum Corp (SOLV) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid Tariff Challenges - Investing.com Canada
Solventum sees FY25 adjusted EPS $5.45-$5.65, consensus $5.54 - TipRanks
Earnings call transcript: Solventum’s Q1 2025 results show mixed performance - Investing.com
Solventum reports Q1 adjusted EPS $1.34, consensus $1.22 - TipRanks
Solventum Corp (SOLV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
0.19%
자본화:
|
볼륨(24시간):